Abstract:Objective: The aim: Improving the effects of pregnancy on the fetus and newborn through early diagnosis and timely comprehensive therapy of pregnant women with intrahepatic cholestasis. Patients and methods: Materials and methods: We have conducted a complex examination of 60 women who got pregnant owing to assisted reproductive technologies, with concomitant intrahepatic cholestasis, and 20 practically healthy women with a physiological course of pregnancy and labor (reference group), aged between 18 and 42. The research did not involve pregnant women with chronic liver diseases, viral hepatitis, skin diseases. Womens who underwent the suggested complex drug therapy with Ursofalc, L-arginine and Omega 3, with peroral administration for 14 days according to the following scheme: Ursofalc - 250 mg once a day, L-arginine - 5 ml 3 times a day, Omega 3 - 1 capsule a day. The complex examination of pregnant women with IHC was conducted before and after treatment. We analyzed the data of anamnesis, carried out anthropometric measurements, clinical biochemical examinations of the women with IHC, including the measurement of the levels of alanine aminotransferase, aspartate aminotransferase, total and direct bilirubin, total and placental alkaline phosphatase, leucine aminopeptidase, 5'-nucleotidase, cholic, deoxycholic and chenodeoxycholic acids as wells as their total level. Results: Results: Almost 40 % of women with intrahepatic cholestasis gave birth to babies with asphyxia, including severe one in 11.1 % of cases, 1/3 of the newborns were premature, 40% had signs of hypotrophy, and 66.7 % experienced a disturbed course of early neonatal adaptation. There was also a higher level of perinatal mortality. The newborns from women who had undergone the suggested complex therapy presented no cases of hypotrophy, prenatal infection or cerebral circulation disorder. Conclusion: Conclusions: Thus, functional hepatic disorders in women with infertility play a certain role in the carrying of pregnancy after ART, in the development of pregnancy complications and adverse consequences for women and their newborns. The conducted research shows that early diagnosis and timely complex therapy of pregnant women with intrahepatic cholestasis makes it possible to influence the pathogenesis of perinatal complications and improve the consequences of pregnancy for the fetus and the newborn.

EP11.03: Plasmapheresis in pregnancy: a novel treatment for acute liver disease of unknown origin with favourable maternal and fetal outcomes

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

Methotrexate for the Placenta in Situ in Advanced Abdominal Pregnancy: A Case of Remaining Intra-Abdominal Infection and Myelosuppression after Methotrexate Treatment

EP06.49: Prenatal detection of large complicated lympho‐venous malformation: effective and safe maternal sirolimus treatment

EP11.14: Incidence of intrahepatic cholestasis in pregnancy and assessment of maternal and fetal prognosis

Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action

Relationship Between Umbilical Artery Doppler Waveform Analysis and Perinatal Prognosis in Women with Intrahepatic Cholestasis of Pregnancy

EP10.22: Maternal propranolol treatment for fetal pleural effusion: a case report

Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients

EP17.17: Plasma sFlt‐1/PlGF ratio as multiples of the median predicts pre‐eclampsia with severe features within two weeks

CONDITION OF FETURES AND NEWBORNS FROM WOMEN WITH INFERTILITY TREATED WITH ASSISTED REPRODUCTIVE TECHNOLOGIES AND WITH CONCOMITANT INTRAHEPATIC CHOLESTASIS

Timely identification and successful treatment of acute fatty liver of pregnancy without obvious clinical symptoms Case reports

Combined Blood Purification for Treating Acute Fatty Liver of Pregnancy Complicated by Acute Kidney Injury: a Case Series

Acute Fatty Liver Of Pregnancy: A Retrospective Analysis Of 13 Cases

Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report

Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases.

EP11.19: A rare presentation: suspected hemolytic uremic syndrome in early pregnancy

EP10.05: Postnatal follow up of successful intraperitoneal injection of amiodarone for fetal hydrops with tachyarrhythmia

EP12.10: Cardiac disease in pregnancy and perinatal outcomes

State of the Art in Hepatic Dysfunction in Pregnancy

Acute Fatty Liver of Pregnancy: Analysis on the Diagnosis and Treatment of 15 Cases.